Literature DB >> 22434228

Advanced necrotizing enterocolitis part 2: recurrence of necrotizing enterocolitis.

M Thyoka1, S Eaton, N J Hall, D Drake, E Kiely, J Curry, K Cross, P de Coppi, A Pierro.   

Abstract

AIM OF THE STUDY: The aim of this study was to report incidence and clinical outcomes of recurrent necrotizing enterocolitis (NEC).
METHODS: Review of infants treated for recurrent episode(s) of NEC at a tertiary Neonatal Surgical Intensive Care Unit over 8 years (January 2002 to February 2011). Demographic, clinical, radiological, and operative data were analyzed and compared using Mann-Whitney or Fisher's exact tests. Data are reported as median (range).
RESULTS: A total of 212 consecutive infants were referred for surgical evaluation and treatment of NEC (Bell stage II or III). Of these patients, 22 (10%) had suspected recurrent NEC: in 11 of these the primary episode was Bell stage I successfully treated before coming to our institution (suspected recurrent NEC); in the remaining 11, the primary episode was confirmed (Bell stage II or III) NEC successfully treated in our hospital. Birth weight, gestational age at birth, corrected gestational age, weight on admission, gender, need for surgery, stricture, and mortality rates were similar between infants with recurrent NEC and those with a single episode. Long-term parenteral nutrition (PN) dependency (>28 days) was significantly more common following recurrent NEC compared with a single episode. Among the infants with recurrent NEC, medical therapy alone was not successful in the majority (82%) of cases during the first episode and all required surgery during the recurrent episode.
CONCLUSION: Infants (10%) referred for surgical treatment of NEC develop recurrence of the disease. Surprisingly, these infants have similar mortality and stricture rates to those with a single episode. However, the incidence of long-term PN dependency was significantly increased in those with recurrent episodes of NEC. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2012        PMID: 22434228     DOI: 10.1055/s-0032-1306264

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  8 in total

1.  No relationship between mode of delivery and neonatal mortality and neurodevelopment in very low birth weight infants aged two years.

Authors:  Jia-Jun Zhu; Ying-Ying Bao; Guo-Lian Zhang; Li-Xin Ma; Ming-Yuan Wu
Journal:  World J Pediatr       Date:  2014-08-15       Impact factor: 2.764

Review 2.  Necrotizing enterocolitis: new insights into pathogenesis and mechanisms.

Authors:  Diego F Niño; Chhinder P Sodhi; David J Hackam
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-08-18       Impact factor: 46.802

3.  Evaluation of Time to Resolution of Medical Necrotizing Enterocolitis Using Severity-Guided Management in a Neonatal Intensive Care Unit.

Authors:  Katelyn E Bull; Andrew B Gainey; Christina L Cox; Anna-Kathryn Burch; Martin Durkin; Robert Daniels
Journal:  J Pediatr Pharmacol Ther       Date:  2021-02-15

Review 4.  Evidence-based feeding strategies before and after the development of necrotizing enterocolitis.

Authors:  Misty Good; Chhinder P Sodhi; David J Hackam
Journal:  Expert Rev Clin Immunol       Date:  2014-06-05       Impact factor: 4.473

5.  Neonatal independent predictors of severe NEC.

Authors:  Miriam Duci; Francesco Fascetti-Leon; Marta Erculiani; Elena Priante; Maria Elena Cavicchiolo; Giovanna Verlato; Piergiorgio Gamba
Journal:  Pediatr Surg Int       Date:  2018-04-11       Impact factor: 1.827

Review 6.  Necrotizing enterocolitis: controversies and challenges.

Authors:  Augusto Zani; Agostino Pierro
Journal:  F1000Res       Date:  2015-11-30

7.  Global incidence of Necrotizing Enterocolitis: a systematic review and Meta-analysis.

Authors:  Amer Alsaied; Nazmul Islam; Lukman Thalib
Journal:  BMC Pediatr       Date:  2020-07-13       Impact factor: 2.125

Review 8.  Necrotizing enterocolitis and congenital heart disease.

Authors:  Hadi Kashif; Eyad Abuelgasim; Nafisa Hussain; Jessica Luyt; Amer Harky
Journal:  Ann Pediatr Cardiol       Date:  2022-03-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.